300583 Stock Overview
Researches and develops new steroid biomedicine intermediates.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Shandong Sito Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.72 |
| 52 Week High | CN¥24.20 |
| 52 Week Low | CN¥10.66 |
| Beta | 0.32 |
| 11 Month Change | 49.18% |
| 3 Month Change | 100.00% |
| 1 Year Change | 37.78% |
| 33 Year Change | 68.92% |
| 5 Year Change | 17.30% |
| Change since IPO | -37.35% |
Recent News & Updates
Recent updates
Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up
Sep 27
Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge
Jun 06There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings
May 05Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%
Apr 16Shareholder Returns
| 300583 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.1% | 1.6% | 2.7% |
| 1Y | 37.8% | 0.7% | 4.6% |
Return vs Industry: 300583 exceeded the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 300583 exceeded the CN Market which returned 4.6% over the past year.
Price Volatility
| 300583 volatility | |
|---|---|
| 300583 Average Weekly Movement | 12.6% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 300583's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300583's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,200 | Lianbiao Jin | www.sitobiotech.com |
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tetraene, androstenedione, ketal, 3-ketal, norandrostenedione, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Shandong Sito Bio-technology Co., Ltd. Fundamentals Summary
| 300583 fundamental statistics | |
|---|---|
| Market cap | CN¥4.31b |
| Earnings (TTM) | -CN¥1.15m |
| Revenue (TTM) | CN¥1.18b |
3.6x
P/S Ratio-3,741x
P/E RatioIs 300583 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300583 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.18b |
| Cost of Revenue | CN¥947.40m |
| Gross Profit | CN¥235.37m |
| Other Expenses | CN¥236.52m |
| Earnings | -CN¥1.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 29, 2024
| Earnings per share (EPS) | -0.0061 |
| Gross Margin | 19.90% |
| Net Profit Margin | -0.097% |
| Debt/Equity Ratio | 36.6% |
How did 300583 perform over the long term?
See historical performance and comparison